(Press-News.org) Intermittent fasting has proven benefits for metabolic health, but a new study shows that it could slow hair growth—at least in mice. Researchers report December 13 in the Cell Press journal Cell that mice subjected to intermittent fasting regimes showed improved metabolic health but slower hair regeneration compared to mice with 24/7 access to food. A similar process might occur in humans, based on a small clinical trial that the team also conducted, but it’s likely to be less severe since humans have a much slower metabolic rate and different hair growth patterns compared to mice.
“We don't want to scare people away from practicing intermittent fasting because it is associated with a lot of beneficial effects—it's just important to be aware that it might have some unintended effects,” says senior author and stem cell biologist Bing Zhang (@bingzhang_lab) of Westlake University in Zhejiang, China.
In addition to its metabolic benefits, previous studies have shown that fasting can improve the stress resistance of stem cells associated with blood, intestinal, and muscle tissue, but little is known about how it impacts peripheral tissues such as skin and hair. Zhang’s team hypothesized that fasting might also be beneficial for skin tissue regeneration, the process by which old and damaged cells are replaced.
To test this, they examined hair regrowth in mice that were shaved and then subjected to different intermittent fasting regimes. Some mice were fed on a time-restricted feeding (TRF) schedule that involved 8 hours of food access and 16 hours of fasting each day, while other mice were subjected to alternate-day feeding (ADF).
They were surprised to find that fasting inhibited hair regeneration. While control mice that had unlimited access to food had regrown most of their hair after 30 days, mice on both intermittent fasting regimes showed only partial hair regrowth after 96 days.
The team showed that this inhibited hair growth occurs because hair follicle stem cells (HFSCs) are unable to cope with the oxidative stress associated with switching from using glucose to fat. HFSCs go through phases of activity and dormancy, and hair regrowth depends on these cells becoming active. While the control mice’s HFSCs began to become activated around day 20 post-shaving and remained active until their hair had regrown, the intermittent fasting mice’s activated HFSCs underwent apoptosis (programmed cell death) during extended fasting periods.
Using genetic engineering methods, the team showed that this fasting-induced apoptosis was driven by an increased concentration of free fatty acids near the hair follicles, which caused a build-up of harmful radical oxygen species within the HFSCs. Free fatty acids also caused human HFSCs to undergo apoptosis in vitro.
“During fasting, adipose tissue starts to release free fatty acids, and these fatty acids enter the HFSCs that were recently activated, but these stem cells don't have the right machinery to use them,” says Zhang.
In comparison, epidermal stem cells, which are responsible for maintaining the epidermal skin barrier, were unaffected by intermittent fasting. The major difference between these stem cell types is that epidermal stem cells have a higher antioxidant capacity. When the team tested whether antioxidants could mitigate the effects of fasting on hair growth, they showed that both topical application of vitamin E and genetic upregulation of antioxidant capacity helped HFSCs survive fasting.
The team also conducted a small clinical trial with 49 healthy young adults to examine whether fasting similarly affects hair regrowth in humans. They showed that a time-restricted diet involving 18 hours of fasting per day reduced the average speed of hair growth by 18% compared to controls, but larger studies would be needed to verify this effect given the study’s small sample size and short duration (10 days).
“The human population is very heterogeneous, so the effects might be different for different people,” says Zhang. “Mice also have a very high metabolic rate compared with humans, so fasting and metabolic switching have a more severe effect on mouse HFSCs. We see a milder effect in humans—there are still apoptotic stem cells, but many HFSCs survive. So, there is still hair regrowth; it’s just a little bit slower than usual.”
In future work, the researchers plan to collaborate with local hospitals to investigate how fasting impacts other types of stem cells in the skin and other body systems.
“We plan to examine how this process affects the regeneration activities in other tissues,” says Zhang. “We also want to figure out how fasting impacts skin wound healing and identify metabolites that could help the survival of HFSCs and promote hair growth during fasting.”
###
This research was supported by the National Natural Science Foundation of China, the Key R&D Program of Zhejiang, the Westlake Laboratory of Life Sciences and Biomedicine, the Research Center for Industries of the Future (RCIF), and the Center of Synthetic Biology and Integrated Bioengineering at Westlake University.
Cell, Chen, Liu, and Cui et al., “Intermittent Fasting-induced Lipolysis in Niche Adipocytes Drives Hair Follicle Stem Cell Apoptosis” https://cell.com/cell/fulltext/S0092-8674(24)01311-4
Cell (@CellCellPress), the flagship journal of Cell Press, is a bimonthly journal that publishes findings of unusual significance in any area of experimental biology, including but not limited to cell biology, molecular biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. Visit http://www.cell.com/cell. To receive Cell Press media alerts, contact press@cell.com.
END
Intermittent fasting inhibits hair regeneration in mice
2024-12-13
ELSE PRESS RELEASES FROM THIS DATE:
Changes in adult obesity trends in the US
2024-12-13
About The Study: The findings of this study suggest that body mass index and obesity prevalence in the U.S. decreased in 2023 for the first time in more than a decade. The most notable decrease was in the South, which had the highest observed per capita glucagon-like peptide 1 receptor agonist (GLP-1RA) dispensing rate. However, dispensing does not necessarily mean uptake, and the South also experienced disproportionately high COVID-19 mortality among individuals with obesity.
Corresponding Author: To contact the corresponding author, Benjamin Rader, PhD, MPH, email benjamin.rader@childrens.harvard.edu.
To ...
Prevalence of post–COVID-19 condition and activity-limiting post–COVID-19 condition among adults
2024-12-13
About The Study: In 2023, among 29,522 respondents to the National Health Interview Survey, a nationally representative household survey, 8.4% of adults in the U.S. reported they ever had post–COVID-19 condition (PCC; also known as long COVID), 3.6% currently had PCC, and 2.3% currently had activity-limiting PCC. Significant differences across all 3 outcomes were observed by sex, sexual orientation, age, race and Hispanic origin, family income, and urbanization.
Corresponding Author: To contact the corresponding author, Anjel Vahratian, PhD, MPH, email avahratian@cdc.gov.
To access the embargoed study: Visit our For The Media website ...
Scientists innovate breeding strategies to create climate-smart crops
2024-12-13
A recent study has reported a novel breeding strategy to rapidly create climate-smart crops that show higher yield under normal conditions and greatly rescue yield losses under heat stress both in staple grain and vegetable crops.
The study, which was published in Cell on 13 December, was conducted by Prof. XU Cao’s team from the Institute of Genetics and Developmental Biology (IGDB) of the Chinese Academy of Sciences.
The year 2050 is fast approaching and farm productivity must increase by 60% in order to feed a projected global population of 10 billion. However, current crop production is insufficient and is expected to worsen due to the abiotic-stress burden ...
The genetic basis of fertility, family and longevity
2024-12-13
Led by researchers from the University of Oxford’s Leverhulme Centre for Demographic Science and the University of Iceland, the review explores how genetic variations can explain differences in reproductive health and longevity.
The study provides the most comprehensive review of male and female genetic discoveries of reproductive traits to date, and provides new insights into how our DNA affects when we have children, the timing of menopause, and even how that is connected to how long we live.
Genes at the heart of reproduction
Using the GWAS Catalog, an online database of Genome Wide Association Studies (GWAS), the researchers identified ...
Exposure to remote wildfire smoke drifting across the US linked to increased medical visits for heart and lung problems
2024-12-13
Wildfire smoke has long been known to exacerbate health problems like heart disease, lung conditions, and asthma, but now a new study finds that smoke from these fires can lead to poor health thousands of miles away. Researchers from the University of Maryland Institute for Health Computing (UM-IHC) found that medical visits for heart and lung problems rose by nearly 20 percent during six days in June, 2023, when smoke from Western Canadian wildfires drifted across the country, leading to very poor air quality days in Baltimore and ...
Northwestern University joins Giant Magellan Telescope International Consortium
2024-12-13
PASADENA, CA – December 13, 2024 – The Giant Magellan Telescope announced today that Northwestern University has joined its international consortium to construct the $2.54 billion observatory.
Home to the world-renowned Center for Interdisciplinary Exploration and Research in Astrophysics (CIERA) and the newly founded NSF-Simons AI Institute for the Sky (SkAI), Northwestern is at the forefront of advancing astrophysical research. Northwestern researchers will develop and apply cutting-edge artificial intelligence ...
HR-positive, HER2-negative breast cancer patients with high risk of recurrence may benefit from addition of anthracyclines to taxane- based chemotherapy
2024-12-13
SAN ANTONIO – Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of recurrence based on the OncotypeDX genomic test had better outcomes when treated with adjuvant anthracycline- plus taxane-based chemotherapy regimens compared with those receiving adjuvant taxane-based chemotherapy regimens alone, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
“HR-positive, HER2-negative is the most common type of breast cancer in the United States and we frequently need to decide whether or not adjuvant chemotherapy ...
ZEST trial offers insights for using ctDNA to predict breast cancer recurrence
2024-12-13
SAN ANTONIO – The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating tumor DNA (ctDNA), failed to accrue enough patients positive for ctDNA, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
As some of the lessons learned from this trial, investigators suggest beginning ctDNA testing during treatment rather than waiting for treatment completion as done in ZEST, and including patients with high- risk ...
Multimodal machine learning model effective at predicting response to CDK4/6 inhibitors in HR-positive, HER2-negative breast cancer patients
2024-12-13
SAN ANTONIO – A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer would have better outcomes from adding CDK4/6 inhibitors to endocrine therapy as first-line treatment, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
While the use of CDK4/6 inhibitors combined with endocrine therapy have significantly improved outcomes in patients with HR-positive, ...
Light-induced gene therapy disables cancer cells’ energy center
2024-12-13
COLUMBUS, Ohio – Researchers are shining a light on cancer cells’ energy centers – literally – to damage these power sources and trigger widespread cancer cell death.
In a new study, scientists combined strategies to deliver energy-disrupting gene therapy using nanoparticles manufactured to zero in only on cancer cells. Experiments showed the targeted therapy is effective at shrinking glioblastoma brain tumors and aggressive breast cancer tumors in mice.
The research team overcame a significant challenge to break ...